Human SMYD2 ELISA Kit (HUFI08449)

SMYD2 (SET and MYND domain-containing protein 2) is a lysine methyltransferase that methylates histone H3 at lysine 36 and non-histone tumor suppressor substrates such as p53, positioning this analyte as a meaningful biomarker in cancer epigenetics research. This ELISA kit from Assay Genie provides quantitative measurement of human SMYD2 protein in clinical research specimens collected from cancer patients and healthy donors, supporting translational workflows that link chromatin-modifying enzyme abundance to disease state.

Each kit contains reagents sufficient for 96 individual determinations and is configured for in vitro research applications including enzyme regulation studies, methyltransferase inhibitor screening, and pathway analysis in disease models such as leukemia, hepatocellular carcinoma, and breast cancer. The format enables laboratories to generate standardized concentration data for correlation with gene expression profiles, drug response studies, or disease staging investigations.

Typical research applications include:

• Quantifying SMYD2 protein abundance across tumor-derived and matched normal samples
• Evaluating the effect of small-molecule methyltransferase inhibitors on cellular SMYD2 levels
• Characterizing SMYD2 expression within patient cohorts for biomarker discovery
• Validating SMYD2 as a therapeutic target or prognostic indicator in oncology studies

All reagents are validated for human reactivity and intended for research use only, supporting studies that investigate SMYD2's contribution to tumor progression, chromatin remodeling, and post-translational regulatory networks.